Utama › Kanser Paru-paru › New York › Queens
Kajian klinikal Kanser Paru-paru di Queens, NY
22 kajian untuk Kanser Paru-paru sedang mencari peserta di lokasi dalam dan sekitar Queens (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Mengambil pesertaFasa 3
- Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi jauh
Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi jauh
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Queens Hospital Center, Jamaica · 2 mi jauh
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Mengambil pesertaFasa 3
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi jauh
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Mengambil pesertaFasa 3
- Optum Medical Care, PC, Westbury · 14 mi jauh
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
Mengambil pesertaFasa 2
- MSK Nassau, Uniondale · 13 mi jauh
A Registry for People With Lung Cancer
Mengambil pesertaKajian pemerhatian
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi jauh
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Mengambil pesertaFasa 2/3
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 mi jauh
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Mengambil pesertaFasa 1
- NYU Langone Hospital - Long Island Investigational Pharmacy, Mineola · 11 mi jauh
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Mengambil pesertaFasa 3
- Clinical Research Alliance, Westbury · 14 mi jauh
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Mengambil pesertaFasa 3
- Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success · 9 mi jauh
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 mi jauh
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Mengambil pesertaFasa 1
- NYU Langone Health - Long Island, Mineola · 11 mi jauh
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Mengambil pesertaFasa 3
- Northwell Health/R.J. Zuckerberg Cancer Center, Lake Success · 9 mi jauh
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Mengambil pesertaFasa 3
- NYU Langone Hospital - Long Island, Mineola · 11 mi jauh
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi jauh
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Mengambil pesertaFasa 3
- Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi jauh
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi jauh
A Study of Lung Cancer Risk
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi jauh
A Study of a Side Effects and Resource Navigation Program for People With Cancer
Mengambil peserta
- Memorial Sloan Kettering Nassau (All protocol activities), Rockville Centre · 10 mi jauh
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Mengambil pesertaFasa 1/2
- Clinical Research Alliance, Westbury · 14 mi jauh
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Nassau, Rockville Centre · 10 mi jauh
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi jauh
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Mengambil pesertaKajian pemerhatian
- Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi jauh
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Hempstead · 12 mi jauh
Kajian Kanser Paru-paru di bandar lain
- Houston, TX78 kajian
- Boston, MA62 kajian
- New York City, NY60 kajian
- Los Angeles, CA45 kajian
- Washington, DC41 kajian
- Arlington, VA41 kajian
- Chicago, IL41 kajian
- Nashville, TN40 kajian
- Baltimore, MD40 kajian
- St. Louis, MO39 kajian
- Columbus, OH37 kajian
- Philadelphia, PA36 kajian
Kajian lain di Queens
- Kanser Payudara63 kajian
- Kanser Paru-paru Bukan Sel Kecil49 kajian
- Kanser Kolorektal31 kajian
- Kanser Metastatik28 kajian
- Kanser Ovari28 kajian
- Kanser Prostat27 kajian
- Kanser (semua jenis)26 kajian
- Kanser Endometrium25 kajian
- Leukemia Mieloid Akut21 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher20 kajian
- Mieloma Pelbagai20 kajian
- Kanser Pankreas20 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.